Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment

19 Mar 2025

Abstract excerpt

BACKGROUND: Genes that participate in the absorption, distribution, metabolism, excretion (ADME) processes occupy a central role in pharmacokinetics. Meanwhile, variability in clinical outcomes and responses to treatment is notable in bladder cancer (BLCA). METHODS: Our study utilized expansive datasets from TCGA and the GEO to explore prognostic factors in bladder cancer. Utilizing both univariate Cox regression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40108724
DOI: 10.1186/s41065-025-00409-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatmentPMID 40108724Read ↗

Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune LandscapesSemantic proximity Read ↗

Telomere maintenance-related genes are important for survival prediction and subtype identification in bladder cancerSemantic proximity Read ↗

Targeting Macrophage-Associated Core Genes for Prognostic Prediction and Therapeutic Insights in Bladder CancerSemantic proximity Read ↗

Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA)Semantic proximity Read ↗

Development and validation of a exosome-related gene signature for predicting prognosis, immune infiltration and immunotherapeutic response in bladder cancerSemantic proximity Read ↗

Predicting bladder cancer survival with high accuracy: insights from MAPK pathway-related genesSemantic proximity Read ↗

New exploration of bladder cancer-related immune gene biomarkers in predicting the prognosis of urinary system tumorsSemantic proximity Read ↗

Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancerSemantic proximity Read ↗

Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironmentSemantic proximity Read ↗

A six-gene prognostic model predicts overall survival in bladder cancer patientsSemantic proximity Read ↗

Prognostic feature based on androgen-responsive genes in bladder cancer and screening for potential targeted drugsSemantic proximity Read ↗

Construction and evaluation of a prognostic risk model of aging-related genes in bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.